Key Events This Week
1 June: Sharp quarterly decline reported; stock drops 4.32%
4 June: Heavy volume selling amid operational concerns; stock falls 4.15%
5 June: Continued weakness with minor decline of 0.25%
Aug 14, 04:01 PM
BSE+NSE Vol: 151

Centenial Surgical Suture Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 01 June 2026, reflecting a significant reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 13 August 2026, providing investors with the latest perspective on the company’s position.
Read full news articleThe next results date for Centenial Surgical Suture Ltd is scheduled for August 14, 2026....
Read full news article
Centenial Surgical Suture Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 01 June 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed below are current as of 09 July 2026, providing investors with the latest view of the company’s position in the market.
Read full news article
1 June: Sharp quarterly decline reported; stock drops 4.32%
4 June: Heavy volume selling amid operational concerns; stock falls 4.15%
5 June: Continued weakness with minor decline of 0.25%
Centenial Surgical Suture Ltd's latest financial results for the quarter ended March 2026 reveal significant operational challenges and a concerning trend in profitability. The company reported net sales of ₹12.58 crores, reflecting a year-on-year decline of 5.48%, which indicates a struggle to maintain revenue momentum. This performance is further compounded by a net profit loss of ₹2.31 crores, marking a drastic year-on-year decrease of 95.76%. The operating profit margin has compressed to 7.39%, down from 15.55% in the same quarter last year, highlighting severe operational stress and inadequate cost management. Additionally, interest costs surged dramatically by 531% quarter-on-quarter to ₹2.21 crores, which has significantly impacted the company's financial health, consuming the entirety of its operating profit and pushing it into a pre-tax loss. Overall, the financial data indicates that Centenial ...
Read full news article
Centenial Surgical Suture Ltd., a micro-cap surgical sutures manufacturer with a market capitalisation of ₹33.00 crores, reported a concerning quarter ended March 2026, with net losses widening to ₹2.31 crores compared to a loss of ₹1.18 crores in the year-ago period. The quarter marked the company's weakest operational performance in recent years, with revenue declining 15.34% sequentially to ₹12.58 crores whilst operating margins compressed to just 7.39%—the lowest in the trailing twelve-month period.
Read full news article
Centenial Surgical Suture Ltd has reported a significant downturn in its financial performance for the quarter ended March 2026, marking a stark reversal from its previously positive trajectory. The company’s key metrics, including net sales, profit after tax, and operating margins, have all deteriorated sharply, signalling mounting challenges in the healthcare services sector for this micro-cap player.
Read full news article
Centenial Surgical Suture Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 12 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 27 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news articleCentenial Surgical Suture Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve 1. To approve Standalone Un-Audited Financial Results for the quarter ended on June 30 2026 pursuant to Regulation 33 of SEBI (LODR) Regulation 2015. 2. To consider and approve appointment of M/s. Utsav Shah & Associates Chartered Accountants as Internal Auditors of the Company for the Financial Year 2026 - 2027. 3. To consider and approve re-appointment of Ms. Anuradha Kashikar (DIN: 00804831) as an Executive Director of the Company for further period of 03 (Three) years. 4. To approve the Book-closure dates as per Regulation 42 of the SEBI (LODR) Regulations 2015 for the purpose of 31st Annual General Meeting of the Company. 5. To fix the date time for convening 31st Annual General Meeting of the Members of the Company through Video conferencing (VC) / Other Audio-Visual means (OAVM) and approve the Draft Notice for the same. 6. Any other business with the permission of chair.
PFA
Intimation under Reg 30 SEBI (LODR) Regulations 2015 - Retirement of Senior Management Personnel (SMP)
(14 Aug 2026)
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available